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in these synchronous adjacent tumors, without increasing signiﬁcantly the treatment time. (3) The only technical limitation:
targets larger than 40 cm.
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Introduction. Branchial cleft cysts (BCC) are a rare entity. Theymay result from the failure of the obliteration of the second branchial
cleft. The proportion of metastatic squamus cell carcinoma (SCC) in cysts initially presumed to be of branchial cleft origin has
been reported to range from 11% to 21%. It is usually presents in the ﬁfth or sixth decades. Lateral cyst masses most often
represent an SCC originating in the epithelium of Waldeyer’s ring-tonsil, tongue base and nasopharynx.
Objective. Treatment with IMRT of squamous cell carcinoma originated on a branchial cyst. Methods: we present a case of a
56-year-old man with a left neck mass lesion in January 2010. The CT scan showed us a superior cervical mass of 21mm (II
level) anteriorly to the jugular vein. In June 2010 our patient underwent complete surgical excision and ipsilateral modiﬁed
radical neck dissection. The histopathologic study reported a squamus cell carcinoma originated on a branchial cyst (3 cm) and
18 lymph nodes free of metastases.
Results. Between Agost 2010 and September 2010 our patient received adyuvant radiotherapy with IMRT technique and integrated
boost. We stablished the following targed volumes: CTV1: tumor bed and CTV2: lymphatyc drainage left levels II, III and IV. We
administred a total dosis of 60Gy to CTV1 and 54Gy to CTV2. The patient presented mucositis grade 1. Twenty-eight months
after the treatment, there was no clinical or radiologic evidence of tumor recurrence.
Conclusion. The management of the branchiogenic squamous cell carcinoma should include extensive excision of tumor and
ipsilateral radical neck dissection to improve the cure rate and survival rate. Adjuvant radiotherapy is recommended to improve
prognosis. IMRT technique enables the target volume to be limited, potentially reducing the ﬁeld of radiation to the radiosensitive
larynx and nasopharynx.
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Introduction. Helical tomotherapy (HT), an image-guided intensity-modulated radiotherapy technique, allows an accurate target
irradiation while sparing surrounding normal tissue. Objective(s): to evaluate the feasibility of HT in locally advanced nasopha-
ryngeal carcinoma (LANPC) patientswith intracraneal extension and/or involvement of cranial nerves (IVa) or lymphnodes >6 cm
and/or extension to supraclavicular fossa (IVb).
Materials and methods. From August 2009 to January 2013, 17 LANPC patients (IVa stage: 82%; IVb 18%) were treated with HT
and simultaneous integrated boost technique. A median dose of 70Gy to gross tumor volume and positive neck nodes with
margin, 66Gy to high-risk areas and 54Gy to clinically negative neck, in 33 fractions, with concomitant/adjuvant platinum-
based chemotherapy was delivered. Toxicity grading was based on RTOG criteria. Local, locorregional, distant control and overall
survival rates were calculated by using Kaplan–Meier method.
Results. Median follow-up was 16 months (range, 3–36 months). Fifteen complete responses (CR) and 2 partial responses (PR) were
showed. The toxicity RTOG ≥3 was: acute: grade 3: 65% (radiodermatitis n=4, mucositis n=10, aplasia n=1), grade 4: 18% (aplasia:
n=3); late: grade 3: 7.5% (xerostomia: n=3, dysphagia n=1), Grade 4: 0%. Acute/late grade 5 complications were not observed,
but one patient died with brain tissue lesions (recurrence vs necrosis vs abscess not conﬁrmated). The three-year actuarial local,
locorregional and distant control rate were of 93%, 88% and 86% respectively, and a 3-year actuarial progression free survival and
overall survival rate of 63% and 79% respectively. Twelve patients (71%) are alive without disease, 1 patient had local and regional
nodal failure and two patients distant failure (one of them died due to the disease).
Conclusions. HT showed highly conformal dose-avoidance of critical organs while achieving excellent target volume coverage in
regions of highly complex geometry.
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